Skip to content
Clinical Trials – home

Mifepristone: A Comprehensive Guide for Patients

4 / 5
trials open to patients / all trials
7+
Countries

In short

Mifepristone, also known as RU-486, is a medication that has been the subject of numerous clinical trials for its potential use in treating various medical conditions. Originally developed as an abortion pill, researchers have been exploring its efficacy in treating disorders such as bipolar depression, certain types of cancer, uterine fibroids, Cushing's syndrome, and post-traumatic stress disorder. This article summarizes the key findings from several clinical trials investigating the use of mifepristone in different medical contexts.

What is Mifepristone?

Mifepristone is a medication that has various uses in medical treatment. It's known by several other names, including RU-486, Korlym®, Mifeprex, C1073, Corluxin™, and Corlux™. This drug is primarily known for its ability to block certain hormones in the body, which makes it useful for treating various conditions.

Medical Uses of Mifepristone

Mifepristone has been studied and used for several medical conditions:

  • Pregnancy Termination: It's commonly used for ending early pregnancies.
  • Uterine Fibroids: These are non-cancerous growths in the uterus. Mifepristone has shown promise in reducing their size and associated symptoms.
  • Cushing's Syndrome: This is a condition where the body produces too much of the hormone cortisol. Mifepristone can help manage its symptoms.
  • Certain Cancers: Research is ongoing to explore its potential in treating brain tumors, breast cancer, and other types of cancer.
  • Mental Health Conditions: Some studies have investigated its use in treating bipolar depression.
  • Adrenal Insufficiency: It's being studied as a diagnostic tool for this condition, where the adrenal glands don't produce enough hormones.

How Mifepristone Works

Mifepristone works by blocking the effects of certain hormones in the body:

  • Progesterone Blocker: It prevents the hormone progesterone from working normally. This is how it can end early pregnancies and help with conditions like uterine fibroids.
  • Cortisol Blocker: It also blocks the effects of cortisol, a stress hormone. This is why it's useful in treating Cushing's syndrome.
  • Hormone Receptor Interactions: In some cancers, it may work by interfering with hormone receptors that help cancer cells grow.

Dosage and Administration

The dosage of mifepristone varies depending on what it's being used to treat:

  • For Pregnancy Termination: Usually a single dose of 200mg, followed by another medication called misoprostol.
  • For Uterine Fibroids: Doses ranging from 5mg to 10mg daily have been studied.
  • For Cushing's Syndrome: Doses can range from 300mg to 1200mg per day.
  • For Cancer Studies: Various doses have been used, often around 300mg daily.

It's important to note that mifepristone should only be taken under the close supervision of a healthcare provider, as the dosage needs to be carefully controlled and monitored.

Potential Side Effects

Like all medications, mifepristone can cause side effects. These can include:

  • Nausea and vomiting
  • Fatigue or tiredness
  • Dizziness
  • Headache
  • Skin rash
  • Changes in menstrual bleeding

In some cases, more serious side effects can occur. It's crucial to discuss all potential risks and side effects with your doctor before starting treatment.

Ongoing Research and Future Potential

Scientists are continually studying mifepristone to understand its full potential:

  • Cancer Treatment: Researchers are investigating its use in various types of cancer, including breast cancer and lung cancer.
  • Mental Health: Studies are exploring its potential in treating conditions like bipolar depression.
  • Diagnostic Tool: It's being studied as a way to diagnose certain hormone-related conditions.

These ongoing studies may lead to new uses for mifepristone in the future, potentially expanding its role in medical treatment.

Questions people often ask

Conditions where Mifepristone is being studied

Each condition opens its own overview and trial list

Trials with Mifepristone

Recruiting trials first

See all 5 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).